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Five patients with hepatic (3), pelvic (1) or spinal (1) hydatid cysts received 0 mg/kg/d albendazole for 1-3
months prior to surgery. Daughter cysts were present in the spinal hydatid and in one patient with hepatic
disease. Electron microscope examination of the cyst tissue of the pelvic and the 2 hepatic cysts lacking
daughter cysts showed no evidence of germinal layer, and the protoscoleces were dead. The primary cyst of
the hepatic hydatid with daughter cysts (I month therapy) was also judged dead but some pieces of the
daughter cyst germinal layer appeared normal and had unaffected protoscoleces. The daughter cyst tissue of
the spinal hydatid (3 month therapy) appeared normal and the protoscoleces viable. In view of the
undetermined viability of human hydatids before chemotherapy, treatment of longer than month is
advocated for hepatic cysts, particularly if daughter cysts are present, and longer therapy is indicated for
spinal disease.
INTRODUCTION
Although surgery remains the primary treatment for human hydatid disease, there is a
growing interest in medical treatment, particularly where resection is contraindicated
due to disseminated disease, the condition of the patient or in an adjuvant setting.
Mebendazole was the first drug shown to have an effect albeit inconsistent2-4 and
more encouraging results have been achieved using albendazole5-7.
Efficacy is generally judged clinically or monitored radiographically to determine
cyst regression. When chemotherapy has been followed by surgery, the viability of the
protoscoleces within the cyst has been assessed, but less often has the germinal layer of
the hydatid been examined histologically, and reports ofthe ultrastructure ofthis layer
after therapy have been more rare. Verheyen compared human untreated and
mebendazole-treated hydatid germinal layer using electron microscopy, and AI-
Dabagh et al.9 and Gemmell et al. reported the effect of mebendazole on the
ultrastructure of sheep hydatids. Morris et al. included an ultrastructural study in
their report on albendazole treatment ofpulmonary hydatid cysts in naturally infected
sheep. More recently, Rahemtulla et al.2 used histology and electron microscopy to
examine a resected human hydatid after albendazole therapy, but no ultrastructural
details of the germinal layer were given.
The present communication reports the results ofan ultrastructural examination of
the germinal layer of cysts (primary and daughter where present) removed from 5
patients, all ofwhom had received albendazole therapy prior to surgery.
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MATERIALS AND METHODS
Chemotherapy prior to surgery. The five patients (#1-5) all received albendazole
therapy prior to surgery, and the details of cyst site, dosage, duration of therapy and
viability of protoscoleces at surgery (assessment:eosin exclusion/passage into gerbils)
are given in Table 1.
Electron Microscopy. Pieces of germinal layer and attached laminated layer were
carefully taken from hydatid cysts removed at surgery from the 5 patients. Daughter
cyst material, where present, was processed separately from primary cyst tissue.
Primary fixation was in 3% glutaraldehyde in 0.1M phosphate buffer for a minimum
of 6 h, followed by at least 2 barfer washes prior to post-fixation in buffered 1%
osmium tetroxide for h. Dehydration was in a graded acetone series and embedment
was in Spurr’s resin.
A minimum of 6 pieces/cyst were examined as follows: routine 0.5/m sections of
each tissue piece were stained with Toludine blue and examined by light microscopy.
Ultrasections, from chosen areas of these blocks, were cut and stained with aqueous
uranyl acetate followed by lead citrate and examined in a Philips 200.
Table Cyst site, therapy and protosolex viability
Patient Cyst site Dose (divided) Length of Protosolex viability
and type mg/kg/d therapy (Months) at resection
Liver P 10 Dead
2 Pelvis P 10 3 Dead
3 Liver P 10 2 Dead
3 Spine* D 10 3 Alive
4 Liver P,D 10 Alive
P, Primary cyst; D, Daughter cyst; *, Recurrence
RESULTS
In 2 of the 5 patients (#4,5), live disease, as determined by viable protoscoleces, was
present (Table 1). Both of these patients had daughter cysts.
The ultrastructure of the germinal layer of untreated human hydatid has been
described’3 and is similar to that reported from other intermediate hosts4’5. It is
typically cestode in organisation with a distal cytoplasm connected by internuncial
processes to nucleated tegumentary cytons that house the mitochondria, Golgi stacks,
vesicles etc. Extending from the tegumentary and myocytons are large, irregular,
glycogen-containing processes, and arising from the distal cytoplasm and projecting
into the laminated layer are truncated microtriches (i.e. without spines but possessing a
sub-apical circular baseplate6).
Pieces ofgerminal layer from primary cysts, and. daughter cysts where present, from
the 5 patients (#1-5) were examined at the light (LM) and electron (EM) microscope
level. A minimum of 6 pieces/cyst were examined.
Patient # .Primary hepatic cyst: At neither LM nor EM level was there evidence of
germinal layer tissue.
Patient #2. Primary pelvic cyst: At neither LM nor EM level was there evidence of
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Patient #3. Primary hepatic cyst: At neither LM norEM level was there evidence of
germinal layer tissue.
Patient #4. Daughter spinal cysts" At the LM level, intact germinal layer was present
on 5 of the 6 pieces examined; on the 6th there was, adjacent to the laminated layer, an
ill-defined zone that failed to stain adequately with Toluidine blue.
At theEM level, Figures and 2 are typical ofthe intact germinal layer, and glycogen
reserves and comparatively large mitochrondria with dense matricies can be seen in
Figure 1, whereas the more impoverished germinal layer seen in Figure 2 possesses
large mitochondria, laminated residual bodies and sparse glycogen deposits.
Figure 1 Spinal Daughter Cyst (Patient #4). Germinal layer showing mitochondria(arrows) and glycogen
reserves(G). L,laminated layer, x 11900.
Figure 2 As Figure but a more impoverished germinal layer with very large mitochondria(arrows), sparse
glycogen(G) and lamellated residual bodies(R). L,laminated layer, x 11900.108 K.S. RICHARDS AND D. L. MORRIS
The ill-defined germinal layer of the 6th tissue piece completely lacked integrity at
the EM level. Occasional vesicles were seen in contact with the laminated later (as in
Figure 4), and lying internal to this, but detached from it, were highly vesiculated
fragments of tissue as shown in Figure 3.
Patient #5. Primary and Daughter hepatic cysts:
Primary cyst. At the LM level, 3 tissue pieces showed no evidence ofgerminal layer;
the other 3 possessed an ill-defined zone that stained inadequately.
Where there was no evidence of germinal layer tissue at LM, the EM study revealed
either no tissue remnants in contact with the laminated layer or, more frequently, a
narrow zone of vesicles (Figure 4). Occasionally, small regions of necrotic tissue, in
which myelin figures, lipid droplets and small autophagacytosed glycogen deposits
could be seen, remained in contact with the laminated layer (Figure 5). More rarely,
profiles as in Figure 6 were observed.
Daughter cyst tissue. At the LM level, no germinal layer was evident in 4 of the 6
pieces examined, the remaining 2 pieces possessing an intact germinal layer with
attached brood capsules in which protoscoleces were present.
Figure 3 As Figure but no intact germinal layer present. Internal to the laminated layer are highly
vesiculated tissue fragments(V), x. 7170.
Figure 4 Hepatic Primary Cyst (Patient #5). A narrow zone of vesicles(arrows) remains in contact with the
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Figure 5 As Figure 4. Necrotic tissue remains in contact with the laminated layer(L). D, distal cytoplasm; P,
lipid droplet; Y, myelin figures; arrow, autophagocytosed glycogen deposits, x 9250.
Figure 6 As Figure 4. Necrotic tissue(N) in contact with the laminated layer(L), x 28200.
EM examination of the 4 pieces lacking germinal layer at the LM level revealed no
tissue remnants whereas the other 2 pieces produced profiles similar to that shown in
Figure 7 in which a nucleus, glycogen deposits, lipid deposits, mitochrondria and
mucopolysaccharide residual bodies can clearly be seen. Occasional cell masses were
observed (not illustrated) and were interpreted as incipient brood capsules. The
ultrasections passed through the wall ofdeveloped brood capsules, the tissue ofwhich
appeared normal and similar to that recorded by Rogan and Richards7 from control
murine and equine tissue. Profiles of protoscoleces were observed and Figure 8 shows
part ofa protoscolex soma. The tissue is indistinguishable from control material taken
from other intermediate hosts 16-18.110 K.S. RICHARDS AND D. L. MORRIS
Figure 7 Hepatic Daughter Cyst (Patient #5). An intact germinal layer is present. L, laminated layer; D,
distal cytoplasm; N, nucleus; G, glycogen; P, lipid; arrow, mitochondrion; S, mucopolysaccharide residual
body. x 3570.
Figure $ Outer part of the soma of a protoscolex within a hepatic daughter cyst (Patient#5). D, distal
cytoplasm; T, tegumentary cyton; N, nucleus; G, glycogen, x 9250.
DISCUSSION
Although the primary cyst wall present in 4 of the 5 patients showed no evidence of
intact germinal layer tissue, it would be uncautious to attribute this, unequivocally, to
albendazole therapy.
In cases ofhuman hydatid, reliable methods of viability assessment prior to therapy
are not available. Scanning methods often fail to reveal dead cysts I- and the germinal
layer does not necessarily collapse. These problems were acknowledged by Rahemtulla
et al.2 but they nevertheless attributed the dead cyst at resection to albendazole
therapy.
In field trials using sheep1’!9 aspiration of pulmonary cysts before therapy is
possible, but this only reveals the viability or otherwise of the protoscoleces and does
not indicate the status of the germinal layer.
The vesicular remnants persisting in contact with the laminated layers ofthe primary
cysts are similar to those currently being reported in a study on the long-term effect of
albendazole on sheep hydatids9 and recorded in secondary murine cysts treated in vivo
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In both sheep and humans, the age ofthe infection is unknown, and disintegration of
the germinal layer through natural death cannot be excluded; in young infections in
mouse the collapse and fragmentation of the layer is certainly more likely to have been
drug-related.
Daughter cysts were present in patients #4 and 5 and intact germinal layer was
observed in both, together with, in patient #5, structurally undamaged protoscoleces.
It would appear that therapy of month in patient #5 was insufficient to allow
adequate penetration and maintenance of effective drug levels within the daughter
cysts to achieve destruction of the germinal layer and protoscoleces. Patient #4 had,
however, received albendazole for 3 months prior to surgery. In this case, the apparent
inefficacy of the drug might be attributed to the possibly privileged site in which this
hydatid occurred. Whilst albendazole does enter the CSF in both man and sheep, the
concentrations are considerably less than those present in the serum.
The evidence gained from this study would suggest that albendazole therapy of
month is probably not sufficient to kill germinal layer reliably, especially that of
daughter cysts, although patients #1-3 (with only primary cysts) had no viable tissue at
the end ofsuch a treatment time. In view of the uncertainty ofthe viability status ofthe
germinal layer and protoscoleces prior to treatment, the duration oftherapy should be
longer than month. In cases of hydatid in the central nervous system, much longer
periods of therapy would seem necessary.
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INVITED COMMENTARY
Whilst surgery is still the primary method of treatment for hydatid disease,
chemotherapy is increasingly recognised as an important adjunct or, in some instances,
alternative. The benzimidazole carbamates mebendazole and albendazole has now
been used extensi(,ely in this role, with the latter drug showing considerably more
promise. This probably relates to the much higher plasma levels (about 100 times
higher) of the metabolite of albendazole achieved following comparable oral doses of
the two compounds.
In the majority of trials of the effectiveness of albendazole against human hydatid
disease 10 mg/Kg/day has been the dosage used but the duration and spacing ofcourses
of treatment has not been standardised. The efficacy of albendazole has usually been
assessed by evidence of cyst regression or by determinations of protoscolex viability
following surgical removal of the cyst. It is highly desirable that studies which will
provide information on the mode of action of such compounds on hydatid cysts,
especially on the germinal layer, are performed if a rational basis for dosages and
duration oftherapy is to be developed. The approach used in the study reported in this
manuscript by Richards and Morris provides some observations ofthis kind but, as the
authors state, it is not possible to unequivocally attribute the effects observed to
albendazole therapy, especially when such small numbers of patients are involved.
Whether the ultrastructural changes found in the non viable cysts are due to
albendazole or not, the paper does provide useful descriptions of apparently normal
and abnormal hydatid cysts from humans which will be valuable for comparative
purposes. In this respect it might have been advantageous to include
photomicrographs from the material removed from the other three patients as well or
to state that the ultrastructure ofthose cysts was identical to that ofthe apparently non-
viable material from patients 4 and 5.
From the results of this study it does seem clear that one month of treatment at
10mg/Kg/day is probably insufficient and this would appear to be supported by
clinical trials in which cyst regression was used as a criterion ofsuccess. Even the three
month course received by patient No. 4 was inadequate and, though it may be true that
the cyst was in a "privaleged site" less accessible to the active drug, it needs to be borneULTRASTRLICTURAL STUDY OF ALBENDAZOLE 113
in mind that four months therapy has not always been successful, even in liver. It is for
this reason of varied response that more studies are needed, both to determine the
effects ofalbendazole and other chemotherapeutic agents on cysts in different sites and
to determine if different hydatid strains respond differently. This paper provides a
useful basis for comparison with future investigation.
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